The objective of the present work is to explore EC diversity during tumour progression on the basis of single‐cell transcriptomics, as well as to validate the mechanism that mediates the transformation of normal ECs into TECs by regulating PLVAP expression in ECs, and the related functions of the PLVAP gene in the TME. The gene discussed is PLVAP; the disease is neoplasm.